EGFR and cancer: Mutations and dysregulations of critical RTKs like epidermal growth factor receptor (EGFR) [1], Src kinases [2], and Numb-associated kinases (NAKs) play a significant role in cell signaling pathways [3], and their inhibition has been proven to be effective in combating various cancer types [4].